Breaking News
How Might Washington's Relations With Ukraine & Russia Change If It Abandons Its Peace Efforts?
Divisions Remain As Republicans Steam Ahead With 'Big Beautiful Bill'
El Salvador Works With Nvidia To Develop Sovereign AI Infrastructure
"He Who Has The Gold Makes The Rules" President Trump Proclaims Over Easter Weekend
Top Tech News
'Cyborg 1.0': World's First Robocop Debuts With Facial Recognition And 360° Camera Visio
The Immense Complexity of a Brain is Mapped in 3D for the First Time:
SpaceX, Palantir and Anduril Partnership Competing for the US Golden Dome Missile Defense Contracts
US government announces it has achieved ability to 'manipulate space and time' with new tech
Scientists reach pivotal breakthrough in quest for limitless energy:
Kawasaki CORLEO Walks Like a Robot, Rides Like a Bike!
World's Smallest Pacemaker is Made for Newborns, Activated by Light, and Requires No Surgery
Barrel-rotor flying car prototype begins flight testing
Coin-sized nuclear 3V battery with 50-year lifespan enters mass production
BREAKTHROUGH Testing Soon for Starship's Point-to-Point Flights: The Future of Transportation
Let Stem Cell Donors Be Paid. Lives Depend on It
The report analyses the science and ethics behind the Health Resources and Services Administration's (HRSA) proposed rule to redefine hematopoietic (blood-forming) stem cells (HSC) as an organ. These are the cells that originate in bone marrow but are also found in the bloodstream. Today, over 70% of HSC donations are extracted from the bloodstream through a safe, non-invasive technique known as apheresis, after which the cells quickly regenerate.
In 2011, a federal court ruled compensating donors of HSC by apheresis to be legal due to the procedure's comparability to plasma and whole blood donation. HRSA's rule change would supersede the court and violate congressional intent, thereby making compensation to all HSC donors illegal under the National Organ Transplant Act. HRSA has until December 18th to move forward on its rule.